Arkema (AKE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 sales reached €2.54 billion, up 3.8% year-over-year, with volumes rising 4.7% and a negative 2.4% price effect due to lower raw material prices.
EBITDA increased 8.2% to €451 million, with a margin of 17.8%, reflecting strong performance in adhesives, high performance polymers, fluorogases, and downstream coating solutions.
Adjusted net income was €214 million (€2.87/share), up 3.4% year-over-year.
Strategic progress included the acquisition of Dow's flexible packaging adhesives, investments in EV battery technologies, and ramp-up of the Singapore polyamide 11 plant.
Continued focus on sustainability, with new biodiversity commitments and expanded ISCC+ certification for coating sites.
Financial highlights
Q2 2024 sales: €2,536 million (+3.8% YoY); EBITDA: €451 million (+8.2% YoY); EBITDA margin: 17.8%.
Recurring EBIT at €302 million (+6% YoY); adjusted net income at €214 million (€2.87/share).
Recurring cash flow for Q2 was €132 million, with €170 million in capex and net debt at €3,270 million (net debt/EBITDA: 2.2x).
Free cash flow was €117 million, including a €15 million non-recurring outflow for Singapore platform start-up costs.
Working capital ratio: 15.7% of annualized sales at end-June 2024.
Outlook and guidance
Full-year 2024 EBITDA guidance tightened to €1.53–1.63 billion (vs. €1.5 billion in 2023), with major projects expected to contribute €60 million to EBITDA for the year.
Q3 2024 EBITDA expected to be slightly up year-over-year, including a €15 million impact from German plant flooding.
H2 to benefit from ramp-up of organic projects and continued PM contribution.
Strategic focus remains on organic growth, M&A integration, and innovation for sustainable solutions.
Latest events from Arkema
- EBITDA dropped but cash flow and cost savings were strong, with Asia and growth markets outperforming.AKE
Q4 202526 Feb 2026 - Q3 2024 EBITDA rose 5.4% to €407 million, margin at 17.0%, amid weak demand and tight debt control.AKE
Q3 202416 Jan 2026 - Ambitious growth, innovation, and sustainability drive strong specialty materials performance.AKE
BNPP Exane CEO Conference Presentation13 Jan 2026 - Q3 2024 saw higher sales and EBITDA, with strong specialty materials growth and sustainability focus.AKE
BOFA European Materials Conference 2024 Presentation13 Jan 2026 - Solid Q2 growth and sustainability focus drive higher 2024 EBITDA outlook of €1.53–1.63bn.AKE
Investor presentation13 Jan 2026 - Strong specialty materials growth, resilient margins, and major investments drive future expansion.AKE
Morgan Stanley Chemicals Cannonball Run Field Trip Presentation13 Jan 2026 - EBITDA margin held at 15.2% in Q2 2025, with cost-saving targets doubled for the year.AKE
Q2 202513 Jan 2026 - 2024 EBITDA rose 2.1% to €1.53bn, led by Specialty Materials and Asian growth.AKE
Q4 202418 Dec 2025 - Sales growth in Asia offset weak Western demand, but profits fell; 2025 outlook stable.AKE
Q1 202518 Nov 2025